Persistence is key: Refining immunotherapy response prediction.

Leung, Michelle; McGranahan, Nicholas

Leung, Michelle; McGranahan, Nicholas.

Afiliação

Leung M; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, University College London Cancer Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
McGranahan N; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Electronic address: nicholas.mcgranahan.10@ucl.ac.uk.

Immunity ; 56(3): 472-474, 2023 03 14.

Article em En | MEDLINE | ID: mdl-36921573

Assuntos

Antígeno B7-H1; Imunoterapia; Humanos; Mutação; Antígeno B7-H1/genética; Biomarcadores Tumorais/genética; Carga Tumoral

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google